| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |